TNFRSF11A and breast carcinoma: In contrast to this study, we investigated the association of RANK and RANKL expression with PMD in breast cancer patients of whom 55.1% received neoadjuvant or adjuvant chemotherapy and whose breast cancers had more favorable tumor characteristics.